Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition, such as hypertension, type 2 diabetes mellitus, or dyslipidemia
Activation of GIP receptors may further support fat metabolism and insulin sensitivity, whilst glucagon receptor agonism is believed to increase energy expenditure and promote the breakdown of stored fat (lipolysis)
These medications should be avoided during pregnancy, breastfeeding, or when planning pregnancy (stop in advance according to product guidance)
FC: Formal analysis, Investigation, Methodology, Visualization, Writing original draft, Writing review & editing
US$ 21.24
US$ 25.16
US$ 22.82
US$ 26.43
US$ 27.43
US$ 25.22
